KALA BIO Statistics
NASDAQ: KALAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.2966-0.0634 (-17.61%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 0.3042 +2.56%
KALA BIO by the numbers
KALA BIO has a market capitalization of $5.7 million based on 19.34M shares outstanding. With trailing EPS of $-10.71, KALA BIO is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 53.5% below its 50-day average and 96.8% below its 200-day average.
Average daily trading volume is 1.46M shares, or about $432,806 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KALA valuation vs. peer median
| Metric | KALA | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.74M | $5.58M | +3% |
| Avg. volume | 1.46M | 271.65K | +437% |
Peer median across 8 companies: GELS, PULM, ADXN, ENLV, IMNN, BGMS, CANF, DRMA.
Valuation
- Market cap
- $5.74M
- EPS (TTM)
- $-10.71
- Shares outstanding
- 19.34M
Price and trading
- Previous close
- 0.36
- Open
- 0.3492
- Day range
- 0.2915 – 0.3492
- 52-week range
- 0.2915 – 95.50
- 50-day moving average
- 0.6376
- Beta
- —
- Volume
- 654.46K
- Average volume
- 1.46M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 4, 2025
Additional statistics
- Market Cap
- 5.74M
- Forward Pe
- -0.04
- Eps
- -10.71
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 95.50
- Week52 Low
- 0.29
- Avg Volume
- 1.46M
- Shares Outstanding
- 19.34M
- Ma50
- 0.64
- Ma200
- 9.25
- Earnings Date
- Aug 4, 2025
- Pct From52w High
- -99.69%
- Pct From52w Low
- 1.75%